THE newest target for treating coronary heart disease (CHD), the leading cause of death in Malaysia, is dyslipidaemia.
This fact was brought to public attention at a media tutorial held recently to announce the release of the 3rd Clinical Practice Guidelines (CPG) on the Management of Dyslipidemia.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!